EarningsQ3 2024 Earnings Report

BioMarin Pharmaceutical (BMRN) Q3 2024 Earnings Report

0 Followers

MX:BMRN Q3 2024 EPS Results

Actual EPS$10.13

Consensus EPS$9.78

Beat/MissBeat by +$0.35

One Year Ago EPS$3.87

Actual Revenue$13.67B

Expected Revenue$12.95B

Beat/MissBeat by +$717.14M

YoY Revenue Growth+26.69%

QuarterQ3 2024

Date10/29/2024

TimeAfter Close

Conference CallTuesday, October 29, 2024

MX:BMRN Upcoming Earnings

BioMarin Pharmaceutical's next earnings date is estimated for November 3, 2026, based on past reporting schedules.

MX:BMRN Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 03, 2026	2026 (Q3)	24.58 / -	-2.946	―
Aug 06, 2026	2026 (Q2)	17.44 / 22.10	22.649	-2.44% (-0.55)
May 04, 2026	2026 (Q1)	12.74 / 13.99	17.493	-20.00% (-3.50)
Feb 23, 2026	2025 (Q4)	3.11 / -4.42	11.785	-137.50% (-16.20)
Oct 27, 2025	2025 (Q3)	-5.16 / -2.95	10.128	-129.09% (-13.07)
Aug 04, 2025	2025 (Q2)	15.85 / 22.65	10.128	123.64% (+12.52)
May 01, 2025	2025 (Q1)	13.15 / 17.49	8.471	106.52% (+9.02)
Feb 19, 2025	2024 (Q4)	9.83 / 11.79	2.026	481.82% (+9.76)
Oct 29, 2024	2024 (Q3)	9.78 / 10.13	3.867	161.90% (+6.26)
Aug 05, 2024	2024 (Q2)	6.59 / 10.13	5.34	89.66% (+4.79)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed